Bristol-Myers Squibb Aktie
WKN: 850501 / ISIN: US1101221083
|
31.10.2024 12:24:33
|
Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates
(RTTNews) - Bristol-Myers Squibb Co. (BMY) announced earnings for third quarter that decreased from last year but beat the Street estimates.
The company's earnings came in at $1.211 billion, or $0.60 per share. This compares with $1.928 billion, or $0.93 per share, in last year's third quarter.
Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $3.650 billion or $1.80 per share for the period.
Analysts on average had expected the company to earn $1.49 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 8.4% to $11.892 billion from $10.966 billion last year.
Bristol-Myers Squibb Co. earnings at a glance (GAAP) :
-Earnings (Q3): $1.211 Bln. vs. $1.928 Bln. last year. -EPS (Q3): $0.60 vs. $0.93 last year. -Revenue (Q3): $11.892 Bln vs. $10.966 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
| Bristol-Myers Squibb Co. | 37,22 | -1,64% |
|